7
Participants
Start Date
August 31, 2003
Primary Completion Date
May 31, 2004
Study Completion Date
May 31, 2004
Dengue Vaccine Formulation 17
Tetravalent live attenuated DEN vaccine candidate. Containing dengue serotypes 1,2, and 3 vaccines produced at the Salk Institute and dengue serotype 4 produced at the WRAIR Pilot Bioproduction Facility. Dosage 1 mL administered via injection at Day 0 and Day 60.
Licensed Japanese Encephalitis (JE) Vaccine
Produced by the Thailand GPO using a Beijing strain of JE in liquid form; dosed at 0.5 mL ot 7 and 7.5 months.
Department of Pediatrics, Pharamongkutklao Hospital, Bangkok
Collaborators (1)
GlaxoSmithKline
INDUSTRY
U.S. Army Medical Research and Development Command
FED